Scientific meeting to confirm excellent Zydenar efficacy and safety.

Published: 2006-01-11 06:58:00

Updated: 2006-01-11 06:58:00

Dong-A held a scientific symposium for Zydenar, an anti-impotence drug developed by the Korean scientists at Shilla hotel on Jan. 5 in attendance of 500 urologists in a celebration of its marketing launching.

Prof. Kim Sae-cheol, the president of Korea Society of Urology, chaired the meetin...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK